See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.45▲ 1.55%
← 0H59 page
XStocksXray
Market X-Ray report · 27 October 2026

Accor SA (0H59)

London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026

Key indicators

Last closeEUR 45.37
52-week range37.59 – 53.32
Return, 1 month / 3 months−0.8% / −1.6%
Return, 1 year / 3 years+2.4% / +65.6%
TrendAbove 200-day, below 50-day
RSI (14)49
Volatility (1 year)28.4%
Worst drawdown (1 year)-21.0%
Average daily value traded18.48M EUR
Dividend yield3.0%

Market X-Ray price-based

60/ 100 · High confidence · ahead of 64% of stocks on this exchange
Trend55
Momentum55
Stability (higher is calmer)68
Liquidity78
Income31

Five-year price chart navy: price · brown: 200-day average

17.0326.1135.1944.2753.352021-102023-022024-052025-072026-10

About the company

Accor is a French hospitality company based in Paris that operates and franchises hotels across many countries. Its brands range from economy hotels such as Ibis to midscale names like Novotel and Mercure and upscale properties such as Sofitel. The company serves business and leisure travellers through owned, managed and franchised hotels, and it also runs a loyalty programme for guests and offers related hospitality services.

Accor SA trades under the code 0H59 on the London Stock Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Accor SA (0H59) trades on the London Stock Exchange in UK. It last closed at EUR 45.37 on 27 October 2026.

Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 1,367 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 2.4% and over the last three months it fell 1.6%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Accor SA (0H59)

The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange

Lens and metricValueScoreReading
Trend55 · FairMixed trend against its averages.
Above 200-day average0.4%
From 52-week high-11.7%
Momentum55 · FairTypical recent returns for this exchange.
3-month return-1.6%
6-month return8.8%
12-month return, skipping the last month3.1%
Stability (higher is calmer)68 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)28.4%
Worst drawdown, 1 year (smaller is calmer)-21.0%
Liquidity78 · StrongTrades actively.
Average daily value traded18.48M EUR
Zero-volume days0.0%
Income31 · WeakDividend is small or irregular.
Dividend yield3.0%
Years with dividends4

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Income: Dividend is small or irregular.

Returns

1 week−2.7%
1 month−0.8%
3 months−1.6%
6 months+8.8%
1 year+2.4%
3 years+65.6%
5 years+62.6%

Signals

50-day / 200-day average45.77 / 45.20
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.95

Technical summary

DailyBearish4 bullish · 4 neutral · 8 bearish
WeeklyNeutral6 bullish · 1 neutral · 5 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish

Recent dividends

Ex-dividend dateAmount per share
1 Jun 2026EUR 1.3500
2 Jun 2025EUR 1.2600
5 Jun 2024EUR 1.1800
23 May 2023EUR 0.3400
10 May 2019EUR 1.0500

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026